Needle-based Percutaneous Ablation of Liver Tumors.

NARecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Liver TumorsHCC - Hepatocellular CarcinomaMetastatic Liver Tumor
Interventions
DEVICE

Needle based delivery of INT001 into liver tumors under real-time image guidance

Using ultrasound or CT imaging, the liver tumor is located. Under local anesthesia or, if necessary, intravenous sedation, the needle is inserted through the skin and the needle tip is brought to the center of the liver tumor using image guidance. 1-2 ml of the INT-001 is injected. The needle is removed and a bandaid is applied to the skin entry site. Right after, or as soon as MRI becomes available, MRI is performed to show that the entire tumor has been treated.

Trial Locations (1)

34010

RECRUITING

Koc University Hospital, Topkapı

All Listed Sponsors
lead

inTumo Therapeutics, Inc.

INDUSTRY